Aim – The article considers the results of research of the vascular endothelial growth factor (VEGF) in blood serum in patients with kidney and bladder tumors after surgical intervention. Materials and methods – The total of investigated patients consisted of 75 primary patients with kidney cancer (stages рТ1‑рТ3N0M0), 75 patients with non-muscle-invasive bladder cancer (NMIBC), stages pТа-1NxMoG1–3, 25 patients with cysts of kidneys and 30 healthy patients. Results of research of content of VEGF in patients with kidney cancer and NMIBC in the postoperative period confirmed the role of angiogenesis processes both in the development of tumoral tissue and relapses of disease. Conclusion – Investigations of VEGF in blood serum may be additional method of revealing kidney cancer and NMIBC after surgical treatment of relapses of disease and may influence on the duration of recurrence-free period.
D.A. Durnov, Vasiliy Yu. Mikhailov, N.B. Zakharova, A.N. Ponukalin Vascular endothelial growth factor as a marker of development of relapses in the postoperative period in kidney and bladder tumors // Russian Open Medical Journal, Vol. 1, Issue 3, 2012, pp. 311-0

Increasing interest devoted to technology of high intensity focused ultrasound (high-intensity focused ultrasound, HIFU), basically, is explained by a wide spectrum of potential fields of application at minimum invasiveness of the given method. In oncourology HIFU is applied in prostate and kidney cancer. In case of tumors of renal parenchyma the given technique is being clinically tested, while HIFU is currently used in the practice of European oncourologists in treatment of prostate cancer. The majority of the references describing the results of HIFU application in prostate cancer is based on data of a number of clinical observations. It has been proved that HIFU is a possible method of treatment of highly — and moderate-differentiated tumors, and local relapses after remote radial therapy.
Popkov V.M., Fomkin R.N., Blyumberg B.I. High intensity focused ultrasound (HIFU) as the alternative method of treatment of oncourological diseases // Saratov Journal of Medical Scientific Research, Vol. 8, Issue 4, 2012, pp. 989-995

Aim: The article considers the results of research of the vascular endothelial growth factor (VEGF) in blood serum in patients with kidney and bladder tumors after surgical intervention. Materials and methods: The total of investigated patients consisted of 75 primary patients with kidney cancer (stages pT1-pT3N0M0), 75 patients with non-muscle-invasive bladder cancer (NMIBC), stages pTa-1NxMoG1-3, 25 patients with cysts of kidneys and 30 healthy patients. Results of research of content of VEGF in patients with kidney cancer and NMIBC in the postoperative period confirmed the role of angiogenesis processes both in the development of tumoral tissue and relapses of disease. Conclusion: Investigations of VEGF in blood serum may be additional method of revealing kidney cancer and NMIBC after surgical treatment of relapses of disease and may influence on the duration of recurrence-free period
Durnov D.A., Mikhailov V. Yu., Zakharova N.B., Ponukalin A.N. Vascular endothelial growth factor as a marker of development of relapses in the postoperative period in kidney and bladder tumors // Saratov Journal of Medical Scientific Research, Vol. 7, Issue 3, 2011, pp. 711-714